Africa: WHO Welcomes Historic Decision By Gavi to Fund the First Malaria Vaccine

press release

WHO welcomes the historic decision by the Gavi Alliance Board to invest in the first malaria vaccine programme. The decision secures investment in the long-awaited malaria vaccine and assures that many more children at risk will benefit from this life-saving vaccine and additional malaria prevention.

The Gavi Board approved an investment to support the malaria vaccine introduction, procurement and delivery for Gavi-eligible countries in sub-Saharan Africa in 2022-2025. An initial investment of US$ 155.7 million for 2022-2025 will initiate the implementation of this additional tool to "help drive down child mortality in Africa," according to Gavi.

...

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.